Radiofrequency devices are electronic-electrical products that can emit radio frequency energy through radiation, conduction, or other means. In aesthetic practices, radiofrequency (RF)-based devices are used for skin tightening, collagen production, body contouring, and facial rejuvenation procedures to reduce pain by applying electric current to a small area of nerve tissue.
The advancement of radiofrequency technology in healthcare has been hailed as one of the most rapid. Furthermore, the radiation-based devices market growth across the globe is expected to be driven by the rise in physical appearance & growing geriatric population during the forecast period.
The Global Radiofrequency-based Devices Market is projected to grow at a CAGR of around 13.98% during the forecast period, 2022-27. Radiofrequency (RF) devices are commonly used in cosmetic procedures. These devices are used to stimulate collagen production, tighten skin, contour the body by heating & destroying fat cells, and rejuvenate the face. Rising preference for minimally invasive procedures, increasing ability of radiofrequency ablation systems to treat specific sites of tissue without damaging other tissue, increasing urbanization, and rising awareness about radiofrequency ablation devices are the major factors driving the radiofrequency devices market, among others.
|Study Period||Historical Data: 2017-20|
|Base Year: 2021|
|Forecast Period: 2022-27|
|Regions Covered||North America: The US, Canada, Mexico|
|South America: Brazil, Rest of South America|
|Europe: Germany, France, The UK,Italy, Spain,The Netherlands, Switzerland, Rest-of-Europe|
|Asia-Pacific: Japan, China, India, South Korea, Australia, New Zealand, Singapore, Rest-of-Asia-Pacific|
|Middle East & Africa|
|Key Companies Profiled||Abbott Laboratories, AngioDynamics, Inc., Sisram Medical Ltd, AtriCure, Inc., Avanos Medical, Inc., Boston Scientific Corporation, Conmed Corporation, Cutera, Inc., Medtronic, Plc, Merit Medical Systems, Inc., Smith & Nephew, Stryker Corporation, Venus Concept, Inc., Bramsys Indústriae Comércio Ltd, BVM Medical Limited, Diros Technology Inc., and others.|
|Unit Denominations||USD Million/Billion|
Furthermore, rising technological advancements & modernization will create new opportunities for the radiofrequency devices market during 2022-27. A rapid surge in the operation of radiofrequency ablation (RFA) devices for chronic diseases can be attributed to the trend toward minimally invasive medical procedures. The latest technological advancements, and an increased preference for safer & less expensive surgeries, have fueled the growth of radiofrequency-based products. Additionally, the level of competition in the radiofrequency-based devices market has intensified as the number of new entrants has increased.
The advancement of medical technology has played a significant role in the evolution of radiofrequency-based procedures. These advancements have enabled surgeons to perform surgeries with minimal or no invasiveness and the highest accuracy possible. For example, the FDA approved the 'cooled radiofrequency ablation' procedure in 2017, which is non-invasive & a perfect solution for patients suffering from debilitating chronic pain.
The growing preference for minimally invasive and non-invasive procedures is driving the demand for radiofrequency-based treatment devices. Non-invasive treatments are becoming increasingly popular among women and men seeking alternatives to invasive plastic surgery, such as a facelift. Radiofrequency treatment is an alternative that has few side effects, takes much less time, and is not painful or harmful. As a result, becoming one of the most popular treatments among individuals, hence fueling the growth of the Radiofrequency-based Devices Market during the forecast period.